Skip to main content
TipRanks
Go Ultimate75% OFF

Sarepta Therapeutics (AB3A) Q1 2026 Earnings Report

0 Followers

CH:AB3A Q1 2026 EPS Results

Actual EPS
CHF 2.43
Consensus EPS
CHF 0.82
Beat/Miss
Beat by +CHF 1.61
One Year Ago EPS
-CHF 3.88

CH:AB3A Q1 2026 Revenue Results

Actual Revenue
CHF 616.21M
Expected Revenue
CHF 399.81M
Beat/Miss
Beat by +CHF 216.40M
YoY Revenue Growth
-1.89%

Earnings Announcement Details

Quarter
Q1 2026
Date
05/06/2026
Time
After Close
Conference Call
Wednesday, May 6, 2026
CH:AB3A Upcoming Earnings

Sarepta Therapeutics's next earnings date is estimated for March 3, 2027, based on past reporting schedules.

Q1 2026 Earnings Call Audio

CH:AB3A Q1 2026 Earnings Call
0:00 / 0:00

Q1 2026 Earnings Slide Deck

Q1 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:AB3A Earnings History

CH:AB3A earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 03, 20272026 (Q4)-0.31--3.31――
Nov 05, 20262026 (Q3)0.07-0.23-1.5285.00% (+1.29)
Aug 05, 20262026 (Q2)0.18-0.041.59-102.65% (-1.64)
May 06, 20262026 (Q1)0.822.43-3.88162.61% (+6.31)
Feb 25, 20262025 (Q4)-1.01-3.311.26-362.00% (-4.58)
Nov 03, 20252025 (Q3)-0.61-1.520.29-629.41% (-1.80)
Aug 06, 20252025 (Q2)0.701.590.062600.00% (+1.53)
May 06, 20252025 (Q1)-2.70-3.880.31-1343.24% (-4.19)
Feb 26, 20252024 (Q4)1.591.260.4219.15% (+0.87)
Nov 06, 20242024 (Q3)-0.060.29-0.39173.91% (+0.67)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed